MyCartis Evalution multiplex biomarker analysis platform

Thursday, 09 October, 2014 | Supplied by: MyCartis


MyCartis has announced the launch of Evalution, a multiplex biomarker analysis platform for the life sciences research market.

The digital multiplex analysis platform is tailored to clinical research and pharmaceutical markets and designed to analyse a broad range of protein and nucleic acid-based biomarkers, delivering high-quality data and rapid results. It provides an integrated reaction and detection environment and simultaneous analysis of large numbers of analytes per assay.

The product will support researchers to better understand the role of biomarkers in early disease and risk diagnosis, and patient management. It can analyse an individual’s protein and molecular profile in a single assay plate.

Online: MyCartis
Related Products

Bio-Rad ddPCR KRAS Screening Multiplex Kit

Bio-Rad Laboratories has launched the ddPCR KRAS Screening Multiplex Kit, the latest...

Rivzman's Gilson Pipetman Calibrating Tool Kit

Rivzman Solutions presents a tool for the calibration of what is claimed to be the world's...

SSI UltraFlux RT sealing film

UltraFlux RT is a clear polyolefin film suitable for real-time PCR.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd